Donna Marie Seyfried

Independent Consultant

Donna Marie Seyfried is currently an independent consultant in business development and strategic planning focused on advanced molecular diagnostics and personalized medicine. With over 25 years of corporate experience in the development of emerging markets in biotechnology and healthcare, she has been instrumental in directing strategic investments, market development, and mergers and acquisitions in building high growth, profitable businesses in life sciences, molecular diagnostics and women’s health.

Prior to 2008, Ms. Seyfried served as Vice President, Business Development and Intellectual Property, and was an Officer of Digene Corporation from 1996 to 2007, until the company’s merger with Qiagen in 2007. Digene is a recognized molecular diagnostics leader in gene-based testing for the screening, diagnosis and monitoring of cancers and infectious diseases, focusing on women’s health. Ms. Seyfried was a key member of the Corporate Executive team which built the company and established HPV testing as the new standard of care for cervical cancer screening in women over 30 years old. During 1996-2007 HPV testing revenues grew from less than $5M to over $200M. Digene revolutionized cervical cancer screening with its’ proprietary HPV Test, the only FDA approved test for the human papilloma virus (HPV), the cause of cervical cancer.

Prior to joining Digene in 1996, Ms. Seyfried served as Director of Business Development for Applera (previously The Perkin-Elmer Corporation or "PE"). Ms. Seyfried was instrumental in PE’s strategic acquisitions of Applied Biosystems and Tropix, and directed PE’s strategic investments in several early stage molecular and chip-based companies. From 1987-1993, she served as the PCR Systems Business Manager during its most dynamic growth phase from less than $1m to $100m in revenues. Ms. Seyfried also worked for the Biomedical Products Division of Cambridge Instruments and E.I. Dupont de Nemours & Co.’s Clinical Diagnostics businesses.

Ms. Seyfried received her BS in Biology in 1980 from Lehigh University.

Daniel M. Skovronsky, MD, PhD

Founder and CEO
Avid Radiopharmaceuticals, Inc.

Dr. Skovronsky founded Avid Radiopharmaceuticals in 2005 and currently serves as its CEO. Avid Radiopharmaceuticals is a clinical-stage, product-focused molecular imaging company that has developed proprietary targeting agents to image amyloid plaques, and is currently testing these compounds in clinical trials for the detection of Alzheimer's disease. Prior to establishing Avid Radiopharmaceuticals, Dr. Skovronsky served as Scientific Director of High Throughput Screening and Drug Discovery at the Center for Neurodegenerative Disease Research at Penn from 2004-2005. He also trained at Penn, completing a Pathology residency and a Neuropathology fellowship at the Hospital of the University of Pennsylvania (2001-2005) and receiving an M.D., Ph.D. in Neuroscience from the School of Medicine (1994-2001).

Dr. Skovronsky has more than 20 peer-reviewed publications and has served as principal investigator or co-principal investigator on seven NIH funded grants since 2005. He and Avid Radiopharmaceuticals have received numerous scientific and business awards, such as the Frost & Sullivan Molecular Imaging Technology Innovation of the Year Award in 2007 and the American Society for Investigative Pathology’s Experimental Pathologist-in-Training Award in 2001. Additionally, Philadelphia Business Journal named him as one of their “Forty under Forty” business leaders in the region in 2006, and PharmaVoice Magazine named him among the “Top 100 Pharmaceutical Business Leaders” in 2007.

Sandeep Wadhwa, MD, MBA

Medicaid Program Director
Colorado Department of Health Care Policy and Financing

Sandeep Wadhwa was appointed State Medicaid Director and Chief Medical Officer of the Department in March, 2008.

Dr. Wadhwa is an Associate Clinical Professor of Medicine at the University of Colorado Denver where he continues to sees patients and precept in the Seniors Clinic at the University of Colorado Hospital.

Before joining the Department, Dr. Wadhwa was the Vice President of Care Management Services at McKesson Health Solutions, a business unit of McKesson Corporation, a Fortune 20 company. He worked at McKesson for nine years and while there was responsible for the P/L of its care management services. In this role, he gained extensive experience with Medicaid and Medicare reform and modernization efforts having worked with 10 states on care management programs for fee-for-service clients.

Prior to joining McKesson, Dr. Wadhwa was active in healthcare policy. He worked for the White House and the U.S. Congress, and has testified before six Congressional committees. He also testified before the President's Advisory Commission on Quality and Consumer Protection in the Health Care Industry on developing innovative models of care for vulnerable populations.

Dr. Wadhwa received his undergraduate degree from Wesleyan University and attended medical school at the Cornell University Medical College, where he was elected to the Alpha Omega Alpha Honor Society. He is board certified in internal medicine and geriatrics and completed his residency training and fellowships at the Hospital of the University of Pennsylvania. Dr. Wadhwa also received an MBA from the Wharton School of Business and completed a general internal medicine fellowship at the University of Pennsylvania.